Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?
NeutralHealth

- GLP-1 drugs, originally developed for weight loss and diabetes in humans, are being explored as a potential treatment for obesity in pets, particularly cats and dogs. Recent estimates indicate that approximately 60 percent of pets in the U.S. are obese, with a significant number also suffering from diabetes.
- The introduction of GLP-1 drugs for pets could represent a significant advancement in veterinary medicine, addressing the growing obesity epidemic among pets and improving their overall health and quality of life. This development may also open new markets for pharmaceutical companies specializing in pet health.
— via World Pulse Now AI Editorial System

